コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
2 substrates coated with ligands of integrins lymphocyte function-associated antigen 1 (LFA-1) (alpha(
3 fects are due, in part, to overexpression of lymphocyte function-associated antigen 1 (LFA-1) (CD11a/
5 ght inhibit T cell DNA methylation, increase lymphocyte function-associated antigen 1 (LFA-1) (CD11a/
6 on critically depends on the beta2 integrins lymphocyte function-associated antigen 1 (LFA-1) (CD11a/
7 little is known about their contribution to lymphocyte function-associated antigen 1 (LFA-1) activat
8 the T cell receptor "inside-out" pathway for lymphocyte function-associated antigen 1 (LFA-1) adhesio
9 on of T cells requires rapid upregulation of lymphocyte function-associated antigen 1 (LFA-1) adhesiv
11 udied the folding during biosynthesis of the lymphocyte function-associated antigen 1 (LFA-1) alphaL
12 hesion receptor C5a receptor (C5aR) or CD11a/lymphocyte function-associated antigen 1 (LFA-1) also fa
13 ed by Mannheimia haemolytica binds to bovine lymphocyte function-associated antigen 1 (LFA-1) and ind
17 e proposed that the I domain of the integrin lymphocyte function-associated antigen 1 (LFA-1) could e
18 lator of the adhesiveness of the b2-integrin lymphocyte function-associated antigen 1 (LFA-1) during
19 and microclustering of the integrin receptor lymphocyte function-associated antigen 1 (LFA-1) express
20 ys that regulate the avidity of the integrin lymphocyte function-associated antigen 1 (LFA-1) for its
23 ytes surveyed the glomerular endothelium via lymphocyte function-associated antigen 1 (LFA-1) in the
24 cells also had adhesion defects with reduced lymphocyte function-associated antigen 1 (LFA-1) integri
30 hibition of LKT binding to the CD18 chain of lymphocyte function-associated antigen 1 (LFA-1) on bovi
31 between other molecules, notably by CD28 and lymphocyte function-associated antigen 1 (LFA-1) on T ce
32 portant interactions is between the integrin lymphocyte function-associated antigen 1 (LFA-1) on the
33 ions by monoclonal antibodies (mAbs) against lymphocyte function-associated antigen 1 (LFA-1) or inte
34 VS-like structures enriched in activated lymphocyte function-associated antigen 1 (LFA-1) were ob
35 es down-regulated active forms of integrins, lymphocyte function-associated antigen 1 (LFA-1), and ve
36 ce protein A and an adhesion molecule, human lymphocyte function-associated antigen 1 (LFA-1), has be
37 with DNA methylation inhibitors overexpress lymphocyte function-associated antigen 1 (LFA-1), which
38 es conformational activation of the integrin lymphocyte function-associated antigen 1 (LFA-1), which
39 tistep adhesion cascade that culminates in a lymphocyte function-associated antigen 1 (LFA-1)-depende
40 wed that HPK1 was critical for CXCL1-induced lymphocyte function-associated antigen 1 (LFA-1)-mediate
45 a counterreceptor for the beta 2 integrins: lymphocyte function-associated antigen 1 (LFA-1, CD11a/C
48 iosynthesis of the beta2 integrin subunit of lymphocyte function-associated antigen 1 (LFA-1; CD11a/C
49 ls and monocytes for the leukocyte integrin, lymphocyte function-associated antigen 1 (LFA-1; CD11a/C
50 ibution of the following adhesion molecules: lymphocyte function-associated antigen 1 (LFA-1; CD11a/C
52 mediated by the beta(2)-integrin CD11a/CD18 (lymphocyte function-associated antigen 1 [LFA-1]), which
54 q were found to activate the beta2 integrins lymphocyte function-associated antigen 1 and CR3 for bin
55 inase C was clustered in a central SMAC, and lymphocyte function-associated antigen 1 and talin were
56 in, and IL-6 and inhibited the expression of lymphocyte function-associated antigen 1 in T lymphocyte
57 t to the interface of CD4, CXCR4, talin, and lymphocyte function-associated antigen 1 on the target c
59 cell receptor for agonist pMHC and of LFA-1 (lymphocyte function-associated antigen 1) for ICAM-1 (in
60 gement and molecules involved in attachment (lymphocyte function-associated antigen 1), signaling (Lc
63 lls expressed high levels of B71, B72, CD24, lymphocyte function-associated antigen 1, and intercellu
65 F265S/F292G mutant is potent in antagonizing lymphocyte function-associated antigen 1-dependent lymph
66 plasma membrane of keratinocytes facilitates lymphocyte function-associated antigen 1-dependent T cel
67 ing antibody against (ILFA1), disrupting the lymphocyte function-associated antigen 1-intercellular a
72 thelial diapedesis, and depended on integrin lymphocyte-function-associated antigen 1 (LFA-1) signals
73 cognized by an I domain-containing integrin, lymphocyte-function-associated antigen 1 (LFA-1, or CD11
74 umerous macrophages that expressed increased lymphocyte function associated antigen-1 (LFA-1) immunor
75 ty, and cytoskeletal linkage of the integrin lymphocyte function associated antigen-1 (LFA-1) on huma
76 endent conformational conversion of integrin lymphocyte function associated antigen-1 (LFA-1), the ma
77 M-1 as a co-stimulatory ligand that binds to lymphocyte function associated antigen-1 (LFA-1), thereb
79 d population of blast cells expressing ICAM1/lymphocyte function associated antigen-1 (LFA-1)/CD70 in
83 t of ICAM-1(-/-) mice, and mice deficient in lymphocyte function-associated antigen-1 (CD11a/CD18), a
84 ution crystal structures of the headpiece of lymphocyte function-associated antigen-1 (integrin alpha
85 re treated with anti-CD45RB, anti-ICAM, anti-lymphocyte function-associated antigen-1 (LFA), or the c
86 in, D1, is the binding site for the integrin lymphocyte function-associated antigen-1 (LFA-1) and hum
87 LGL cell lines also expressed high levels of lymphocyte function-associated antigen-1 (LFA-1) and int
90 w that 7HP349, a small-molecule activator of lymphocyte function-associated antigen-1 (LFA-1) and ver
92 As an adhesion receptor, the beta2 integrin lymphocyte function-associated antigen-1 (LFA-1) contrib
93 fusion proteins targeting the human integrin lymphocyte function-associated antigen-1 (LFA-1) efficie
94 tissue sequestration of T cells by altering lymphocyte function-associated antigen-1 (LFA-1) endocyt
95 gulation of costimulatory molecule CD28+ and lymphocyte function-associated antigen-1 (LFA-1) express
96 1 is required for inducing selectin-mediated lymphocyte function-associated antigen-1 (LFA-1) extensi
97 molecules-1 and -3 (ICAM-1 and ICAM-3) with lymphocyte function-associated antigen-1 (LFA-1) have be
99 T-cells to migrate via cross-linking of the lymphocyte function-associated antigen-1 (LFA-1) integri
100 aking use of alpha4beta1 but not of Mac-1 or lymphocyte function-associated antigen-1 (LFA-1) integri
102 stering state of the co-stimulatory molecule lymphocyte function-associated antigen-1 (LFA-1) is modu
105 y attach a variety of labels to the integrin lymphocyte function-associated antigen-1 (LFA-1) on the
107 (PBC), but the importance of ICAM-1 and its lymphocyte function-associated antigen-1 (LFA-1) recepto
108 olecule-1 (ICAM-1) binds more efficiently to lymphocyte function-associated antigen-1 (LFA-1) than mo
110 unity and rely on the activation of integrin lymphocyte function-associated antigen-1 (LFA-1) to medi
111 ding of LtxA to its beta2 integrin receptor (lymphocyte function-associated antigen-1 (LFA-1)) result
112 viously demonstrated that isoflurane targets lymphocyte function-associated antigen-1 (LFA-1), a crit
115 d alpha(L) subunits to give I-less Mac-1 and lymphocyte function-associated antigen-1 (LFA-1), respec
116 line JY undergoes homotypic aggregation in a lymphocyte function-associated antigen-1 (LFA-1)-mediate
119 inserted (I) domain of integrin alphaLbeta2 [lymphocyte function-associated antigen-1 (LFA-1)] binds
122 he regulation of another leukocyte integrin, lymphocyte function-associated antigen-1 (LFA-1, CD11a/C
123 lonal antibodies (mAbs) to Mac-1, but not to lymphocyte function-associated antigen-1 (LFA-1; CD11a/C
124 mcomitans by binding to the beta(2) integrin lymphocyte function-associated antigen-1 (LFA-1; CD11a/C
125 mphocyte activation triggers adhesiveness of lymphocyte function-associated antigen-1 (LFA-1; integri
127 sed expression of the corresponding ligands (lymphocyte function-associated antigen-1 and very late a
129 1 (PSGL-1) can activate the beta(2) integrin lymphocyte function-associated antigen-1 by signaling th
130 tes and EPC, whereas expression of P1H12 and lymphocyte function-associated antigen-1 clearly differe
131 also able to increase T-cell contact through lymphocyte function-associated antigen-1 clustering.
132 se pattern of localization of PKC theta; and lymphocyte function-associated antigen-1 in the immunolo
133 between free unactivated and free activated lymphocyte function-associated antigen-1 increases, the
135 tion of intercellular adhesion molecule-1 or lymphocyte function-associated antigen-1 specific antibo
136 gainst intercellular adhesion molecule-1 and lymphocyte function-associated antigen-1 were without ef
137 adhesion of T cells by the integrins LFA-1 (lymphocyte function-associated antigen-1) and VLA-4 (ver
138 we investigated the roles of CD28 and LFA-1 (lymphocyte function-associated antigen-1) in the activat
142 molecule-1 expression increased after day 3; lymphocyte function-associated antigen-1+ infiltrating l
143 ructures from complement receptor type 3 and lymphocyte function-associated antigen-1, and our new al
144 lectin and to activate integrin alphaLbeta2 (lymphocyte function-associated antigen-1, LFA-1) to slow
145 vitro human Treg adhesion via modulation of lymphocyte function-associated antigen-1, resulting in d
146 patches of intercellular adhesion molecule-1/lymphocyte function-associated antigen-1, the opposite o
147 -1 or its binding site, the alpha subunit of lymphocyte function-associated antigen-1, was not seen i
148 of 0.36 dyne/cm, similar to values found for lymphocyte function-associated antigen-1-dependent adhes
149 ked T-cell receptor-induced up-regulation of lymphocyte function-associated antigen-1-mediated adhesi
150 antibody panel including Ki-67, CD10, CD11a/lymphocyte function-associated antigen 1alpha (LFA-1alph
151 crossreactivity between epitopes of OspA and lymphocyte function-associated antigen 1alpha(L) chain (
152 ulatory molecule CD28, and adhesion molecule lymphocyte function-associated antigen-2 (LFA-2/CD2).
154 cellular domain of the cell adhesion protein lymphocyte function-associated antigen-3 (LFA-3) (CD58)
155 B7-1, intercellular adhesion molecule-1, and lymphocyte function-associated antigen-3 designated TRIC
156 MHC antigens and costimulators (principally lymphocyte function-associated antigen-3, or LFA-3) on t
157 t the CD2-specific fusion protein alefacept (lymphocyte function-associated antigen-3-Ig; LFA -3-Ig)
159 4, the CD4 coreceptor, or the beta2 integrin lymphocyte function-associated antigen (LFA)-1 (CD11a).
161 information has been learned about integrin lymphocyte function-associated antigen (LFA)-1 adhesion,
162 reased firm adhesion and transmigration by a lymphocyte function-associated antigen (LFA)-1 and inter
164 intercellular adhesion molecule (ICAM)-1 and lymphocyte function-associated antigen (LFA)-1 are lymph
167 4 and intercellular adhesion molecule (ICAM)/lymphocyte function-associated antigen (LFA)-1 interacti
168 tivation antigen (VLA)-4 and beta 2-integrin lymphocyte function-associated antigen (LFA)-1 was found
169 entially mediated by the interaction between lymphocyte function-associated antigen (LFA)-1, a cell s
170 hesion step mediated by the beta2 integrins, lymphocyte function-associated antigen (LFA)-1, and Mac-
172 al roles for E- and P-selectins, CD11a/CD18 [lymphocyte function-associated antigen (LFA)-1], alpha4b
173 histocompatibility complex (MHC) class I and lymphocyte function-associated antigen (LFA)-3 antigens
174 eviously shown that LFA3TIP, a soluble human lymphocyte function-associated antigen (LFA)-3 construct
176 noreceptors including T-cell receptor (TCR), Lymphocyte function-associated antigen (LFA-1), and the